.png)
Pd-L1 Biomarker Testing Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : November 2020 Pages : 158 Category: Biotechnology Report Code : HC1113650
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Pd-L1 Biomarker Testing Market By Type (PD-L1 (22C3), PD-L1(28-8), PD-L1 (SP142), PD-L1 (SP263), Other) and Application (Hospital, Diagnostic Center, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Pd-L1 Biomarker Testing Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.On this basis, PD-L1 protein expression on tumor or immune cells emerged as the first potential predictive biomarker for sensitivity to immune checkpoint blockade.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Pd-L1 Biomarker Testing Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Agilent Technologies
- Roche
- Merck
- Bristol-Myers Squibb
- AstraZeneca
- Ono Pharmaceutical
- Regeneron
- Innovent
- Hengrui Medicine
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Pd-L1 Biomarker Testing Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o PD-L1 (22C3)
o PD-L1(28-8)
o PD-L1 (SP142)
o PD-L1 (SP263)
o Other
· Pd-L1 Biomarker Testing Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Diagnostic Center
o Others
· Pd-L1 Biomarker Testing Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Agilent Technologies
o Roche
o Merck
o Bristol-Myers Squibb
o AstraZeneca
o Ono Pharmaceutical
o Regeneron
o Innovent
o Hengrui Medicine
· Pd-L1 Biomarker Testing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Pd-L1 Biomarker Testing Market, By Country
o U.S. Pd-L1 Biomarker Testing Market
o Canada Pd-L1 Biomarker Testing Market
o Mexico Pd-L1 Biomarker Testing Market
o Europe
§ Europe Pd-L1 Biomarker Testing Market, By Country
o UK Pd-L1 Biomarker Testing Market
o Germany Pd-L1 Biomarker Testing Market
o France Pd-L1 Biomarker Testing Market
o Russia Pd-L1 Biomarker Testing Market
o Italy Pd-L1 Biomarker Testing Market
o Rest of Europe Pd-L1 Biomarker Testing Market
o Asia-Pacific
§ Asia-Pacific Pd-L1 Biomarker Testing Market, By Country
o China Pd-L1 Biomarker Testing Market
o Japan Pd-L1 Biomarker Testing Market
o South Korea Pd-L1 Biomarker Testing Market
o India Pd-L1 Biomarker Testing Market
o Southeast Asia Pd-L1 Biomarker Testing Market
o Rest of Asia-Pacific Pd-L1 Biomarker Testing Market
o South America
§ South America Pd-L1 Biomarker Testing Market
o Brazil Pd-L1 Biomarker Testing Market
o Argentina Pd-L1 Biomarker Testing Market
o Columbia Pd-L1 Biomarker Testing Market
o Rest of South America Pd-L1 Biomarker Testing Market
o Middle East and Africa
§ Middle East and Africa Pd-L1 Biomarker Testing Market
o Saudi Arabia Pd-L1 Biomarker Testing Market
o UAE Pd-L1 Biomarker Testing Market
o Egypt Pd-L1 Biomarker Testing Market
o Nigeria Pd-L1 Biomarker Testing Market
o South Africa Pd-L1 Biomarker Testing Market
o TurkeyPd-L1 Biomarker Testing Market
o Rest of MEA Pd-L1 Biomarker Testing Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Pd-L1 Biomarker Testing Market, By Type
5.1. Introduction
5.2. Global Pd-L1 Biomarker Testing Revenue and Market Share by Type (2017-2021)
5.2.1. Global Pd-L1 Biomarker Testing Revenue and Revenue Share by Type (2017-2021)
5.3. PD-L1 (22C3)
5.3.1. Global PD-L1 (22C3) Revenue and Growth Rate (2017-2021)
5.4. PD-L1(28-8)
5.4.1. Global PD-L1(28-8) Revenue and Growth Rate (2017-2021)
5.5. PD-L1 (SP142)
5.5.1. Global PD-L1 (SP142) Revenue and Growth Rate (2017-2021)
5.6. PD-L1 (SP263)
5.6.1. Global PD-L1 (SP263) Revenue and Growth Rate (2017-2021)
5.7. Other
5.7.1. Global Other Revenue and Growth Rate (2017-2021)
6. Pd-L1 Biomarker Testing Market, By Applications
6.1. Introduction
6.2. Global Pd-L1 Biomarker Testing Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Pd-L1 Biomarker Testing Revenue and Revenue Share by Applications (2017-2021)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2021)
6.4. Diagnostic Center
6.4.1. Global Diagnostic Center Revenue and Growth Rate (2017-2021)
6.5. Others
6.5.1. Global Others Revenue and Growth Rate (2017-2021)
7. Pd-L1 Biomarker Testing Market, By Region
7.1. Introduction
7.2. Global Pd-L1 Biomarker Testing Revenue and Market Share by Regions
7.2.1. Global Pd-L1 Biomarker Testing Revenue by Regions (2017-2021)
7.3. North America Pd-L1 Biomarker Testing by Countries
7.3.1. North America Pd-L1 Biomarker Testing Revenue and Growth Rate (2017-2021)
7.3.2. North America Pd-L1 Biomarker Testing Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Pd-L1 Biomarker Testing by Countries
7.4.1. Europe Pd-L1 Biomarker Testing Revenue and Growth Rate (2017-2021)
7.4.2. Europe Pd-L1 Biomarker Testing Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Pd-L1 Biomarker Testing by Countries
7.5.1. Asia-Pacific Pd-L1 Biomarker Testing Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Pd-L1 Biomarker Testing Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Pd-L1 Biomarker Testing by Countries
7.6.1. South America Pd-L1 Biomarker Testing Revenue and Growth Rate (2017-2021)
7.6.2. South America Pd-L1 Biomarker Testing Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Pd-L1 Biomarker Testing by Countries
7.7.1. Middle East and Africa Pd-L1 Biomarker Testing Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Pd-L1 Biomarker Testing Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Agilent Technologies
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Roche
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Merck
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Bristol-Myers Squibb
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. AstraZeneca
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Ono Pharmaceutical
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Regeneron
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Innovent
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Hengrui Medicine
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.1. Global Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Pd-L1 Biomarker Testing Market Forecast by Regions (2022-2027)
9.2.1. North America Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.1.1. United States Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.1.2. Canada Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.1.3. Mexico Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.2. Europe Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.2.1. Germany Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.2.2. France Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.2.3. UK Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.2.4. Russia Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.2.5. Italy Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.3. Asia-Pacific Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.3.1. China Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.3.2. Japan Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.3.3. Korea Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.3.4. India Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.4. South America Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.4.1. Brazil Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.4.2. Argentina Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.4.3. Columbia Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.4.4. Rest of South America Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.5. Middle East and Africa Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.5.3. Egypt Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.5.4. Nigeria Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.5.5. South Africa Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.5.6. Turkey Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Pd-L1 Biomarker Testing Market Forecast (2022-2027)
9.3. Pd-L1 Biomarker Testing Market Forecast by Type (2022-2027)
9.3.1. Pd-L1 Biomarker Testing Forecast by Type (2022-2027)
9.3.2. Pd-L1 Biomarker Testing Market Share Forecast by Type (2022-2027)
9.4. Pd-L1 Biomarker Testing Market Forecast by Applications (2022-2027)
9.4.1. Pd-L1 Biomarker Testing Forecast by Applications (2022-2027)
9.4.2. Pd-L1 Biomarker Testing Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Pd-L1 Biomarker Testing Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Pd-L1 Biomarker Testing Revenue and Revenue Share by Type (2017-2019)
Figure Global PD-L1 (22C3) Revenue and Growth Rate (2017-2019)
Figure Global PD-L1(28-8) Revenue and Growth Rate (2017-2019)
Figure Global PD-L1 (SP142) Revenue and Growth Rate (2017-2019)
Figure Global PD-L1 (SP263) Revenue and Growth Rate (2017-2019)
Figure Global Other Revenue and Growth Rate (2017-2019)
Table Global Pd-L1 Biomarker Testing Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospital Revenue and Growth Rate (2017-2019)
Figure Global Diagnostic Center Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Pd-L1 Biomarker Testing Revenue by Regions (2017-2019)
Figure North America Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure North America Pd-L1 Biomarker Testing Revenue and Growth Rate (2017-2019)
Figure North America Pd-L1 Biomarker Testing by Countries (2017-2019)
Figure North America Pd-L1 Biomarker Testing Revenue (Million USD) by Countries (2017-2019)
Figure United States Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure United States Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Canada Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Mexico Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Europe Pd-L1 Biomarker Testing Revenue and Growth Rate (2017-2019)
Figure Europe Pd-L1 Biomarker Testing by Countries (2017-2019)
Figure Europe Pd-L1 Biomarker Testing Revenue (Million USD) by Countries (2017-2019)
Figure Germany Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Germany Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure France Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure UK Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Russia Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Italy Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Rest of Europe Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Asia-Pacific Pd-L1 Biomarker Testing Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Pd-L1 Biomarker Testing by Countries (2017-2019)
Figure Asia-Pacific Pd-L1 Biomarker Testing Revenue (Million USD) by Countries (2017-2019)
Figure China Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure China Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Japan Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Korea Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure India Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Southeast Asia Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure South America Pd-L1 Biomarker Testing Revenue and Growth Rate (2017-2019)
Figure South America Pd-L1 Biomarker Testing by Countries (2017-2019)
Figure South America Pd-L1 Biomarker Testing Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Brazil Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Argentina Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Columbia Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Rest of South America Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Middle East and Africa Pd-L1 Biomarker Testing Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Pd-L1 Biomarker Testing by Countries (2017-2019)
Figure Middle East and Africa Pd-L1 Biomarker Testing Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Saudi Arabia Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure United Arab Emirates Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Egypt Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Nigeria Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure South Africa Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Turkey Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Pd-L1 Biomarker Testing Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2017-2019)
Table Agilent Technologies Pd-L1 Biomarker Testing Financial Overview
Table Roche Pd-L1 Biomarker Testing Financial Overview
Table Merck Pd-L1 Biomarker Testing Financial Overview
Table Bristol-Myers Squibb Pd-L1 Biomarker Testing Financial Overview
Table AstraZeneca Pd-L1 Biomarker Testing Financial Overview
Table Ono Pharmaceutical Pd-L1 Biomarker Testing Financial Overview
Table Regeneron Pd-L1 Biomarker Testing Financial Overview
Table Innovent Pd-L1 Biomarker Testing Financial Overview
Table Hengrui Medicine Pd-L1 Biomarker Testing Financial Overview
Figure Global Pd-L1 Biomarker Testing Revenue (Millions USD) and Growth Rate (2019-2027)
Table Pd-L1 Biomarker Testing Market Forecast by Regions (2019-2027)
Figure North America Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure United States Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Canada Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Mexico Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Europe Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Germany Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure France Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure UK Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Russia Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Italy Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Rest of Europe Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Asia-Pacific Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure China Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Japan Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Korea Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure India Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Southeast Asia Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure South America Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Brazil Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Argentina Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Columbia Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Rest of South America Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Middle East and Africa Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Saudi Arabia Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure United Arab Emirates Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Egypt Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Nigeria Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure South Africa Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Turkey Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Pd-L1 Biomarker Testing Market Forecast (2019-2027)
Figure Global Pd-L1 Biomarker Testing Forecast by Type (2019-2027)
Figure Global Pd-L1 Biomarker Testing Market Share Forecast by Type (2019-2027)
Figure Global Pd-L1 Biomarker Testing Forecast by Type (2019-2027)
Figure Global Pd-L1 Biomarker Testing Forecast by Applications (2019-2027)
Figure Global Pd-L1 Biomarker Testing Market Share Forecast by Applications (2019-2027)
Figure Global Pd-L1 Biomarker Testing Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|